D011437Chemicals & DrugsD02.092.831890.995804Propylaminesprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBiochemistry and Molecular Biology22326727Garfield CF, Dorsey ER, Zhu S, Huskamp HA, Conti R, Dusetzina SB, Higashi A, Perrin JM, Kornfield R, Alexander GCAcademic pediatricsTrends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr. 2012 Mar-Apr; 12(2):110-6.Acad Pediatr2012-02-10T00:00:002012Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.0.2236220.01900478research area of0.4758830.028683910subject area for32221310Mukherjee S, Erramilli SK, Ammirati M, Alvarez FJD, Fennell KF, Purdy MD, Skrobek BM, Radziwon K, Coukos J, Kang Y, Dutka P, Gao X, Qiu X, Yeager M, Eric Xu H, Han S, Kossiakoff AANature communicationsSynthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins. Nat Commun. 2020 03 27; 11(1):1598.Nat Commun2020-03-27T00:00:002020Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins.Psychiatry and Behavioral Neuroscience-ResearchPublic Health Scienceshttp://kosslab.uchicago.eduKosslabhttp://recombinant-antibodies.orgRecombinant Antibody NetworkBiochem/Mol BioUniversity of ChicagoJon E.GrantJon E. Grant41.78927490000000-87.601250000000001148Grant, Jon E.ProfessorAnthonyKossiakoff1mlmGLIcGOf5hHlsaUXv9Gq0+s+oAnthony Kossiakoff41.78927490000000-87.601250000000001188Kossiakoff, AnthonyProfessorTheodoreKarrisonTheodore Karrison41.78927490000000-87.601250000000002356Karrison, TheodoreResearch ProfessorCraigGarfieldCraig Garfield41.78927490000000-87.60125000000000237Garfield, CraigSomnathMukherjeeSomnath Mukherjee41.78927490000000-87.601250000000002526Mukherjee, SomnathPostdoctoral Scholartrue1true1Postdoctoral ScholarPostdoctoral Scholartrue1ProfessorProfessortrue1ProfessorProfessortrue1Research ProfessorResearch Professor19026407Chamberlain SR, Hampshire A, Müller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJBiological psychiatryAtomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry. 2009 Apr 01; 65(7):550-5.Biol Psychiatry2008-11-20T00:00:002008Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.23896610Stavitskaya L, Seminerio MJ, Healy JR, Noorbakhsh B, Matsumoto RR, Coop ABioorganic & medicinal chemistryEffect of ring-constrained phenylpropyloxyethylamines on sigma receptors. Bioorg Med Chem. 2013 Sep 01; 21(17):4923-7.Bioorg Med Chem2013-07-11T00:00:002013Effect of ring-constrained phenylpropyloxyethylamines on sigma receptors.23318985Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GCPsychiatric services (Washington, D.C.)Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv. 2013 Apr 01; 64(4):339-46.Psychiatr Serv2013-04-01T00:00:002013Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.